Scaling Up Cell Culture Processes: From R&D to Pilot and Production
The development of antibody drugs relies on a well-structured Quality by Design (QbD) approach for upstream production. By leveraging the advantages of Design of Experiments (DoE) and high-throughput parallel bioreactor technology, researchers can efficiently complete laboratory-scale R&D processes. A critical step in this process is the early identification of the relationship between critical quality attributes…